Jin Xu - Tinavi Medical GM Director
| 688277 Stock | 10.66 0.08 0.74% |
Director
Jin Xu is GM Director of Tinavi Medical Technologies
| Age | 50 |
| Address | Building 7, Beijing, China, 100192 |
| Phone | 86 10 8215 6660 |
| Web | https://www.tinavi.com |
Tinavi Medical Management Efficiency
The company has return on total asset (ROA) of (0.0779) % which means that it has lost $0.0779 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1284) %, meaning that it generated substantial loss on money invested by shareholders. Tinavi Medical's management efficiency ratios could be used to measure how well Tinavi Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Tinavi Medical's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 34.4 M, whereas Total Assets are forecasted to decline to about 1.2 B.Similar Executives
| Found 14 records | DIRECTOR Age | ||
| Hui Kuok | China World Trade | 47 | |
| Huansen Gao | Shenzhen Noposion Agrochemicals | 53 | |
| Zhao Gang | Shandong Polymer Biochemicals | 45 | |
| Beng Lim | China World Trade | 56 | |
| Hui Guo | China World Trade | 45 | |
| Mugang Lin | Eastroc Beverage Group | 54 | |
| Meili Liu | Eastroc Beverage Group | 53 | |
| Jing Wang | China World Trade | 59 | |
| Jie Shi | Dymatic Chemicals | 62 | |
| Min Zhu | Dymatic Chemicals | 51 | |
| Bao Chen | Zhangjiagang Freetrade Science | 45 | |
| Guo He | Dymatic Chemicals | 62 | |
| Qiuping Sheng | China World Trade | 55 | |
| Lihua Liu | Eastroc Beverage Group | 51 | |
Management Performance
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0779 |
Tinavi Medical Techn Leadership Team
Elected by the shareholders, the Tinavi Medical's board of directors comprises two types of representatives: Tinavi Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tinavi. The board's role is to monitor Tinavi Medical's management team and ensure that shareholders' interests are well served. Tinavi Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tinavi Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiangcheng Jia, Deputy Mang | ||
| Tiechang Liu, Deputy Manager | ||
| Yuzhu Xing, Deputy CFO | ||
| Min Qi, Financial Controller | ||
| Min Ma, President Director | ||
| Junhui Huang, Board Secretary | ||
| Jin Xu, GM Director |
Tinavi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tinavi Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0779 | ||||
| Profit Margin | (0.95) % | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 4.83 B | ||||
| Shares Outstanding | 449.39 M | ||||
| Shares Owned By Insiders | 34.54 % | ||||
| Shares Owned By Institutions | 12.25 % | ||||
| Price To Book | 4.06 X | ||||
| Price To Sales | 28.43 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Tinavi Stock
Tinavi Medical financial ratios help investors to determine whether Tinavi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tinavi with respect to the benefits of owning Tinavi Medical security.